Flunarizine Hydrochloride Capsules

Capsule formulation, prescription medication

Category:

Psychiatry series

Product accessories:

Request for quotation

Anti-Counterfeiting Inquiry

Product Description

· National Medical Insurance Products
· National Essential Medicines

Specifications: 5 mg (calculated as C26H26F2N2)
Drug category: Western medicine
National Medical Insurance: Class A

Indications: 1. Insufficient cerebral blood supply, vertebral artery ischemia, and post-cerebral thrombosis conditions, among others. 2. Tinnitus and dizziness. 3. Migraine prevention. 4. Adjunctive treatment for epilepsy.

Pharmacology and Toxicology:
This product is a calcium channel blocker. It helps prevent cellular damage caused by pathological intracellular calcium overload resulting from ischemia or other factors.
This product features:
Relieves vascular spasm: Exhibits a sustained inhibitory effect on persistent vasospasm induced by vasoconstrictive substances, particularly noticeable in the basilar and internal carotid arteries—its potency is 15 times greater than that of cerebrozine.
Vestibular inhibitory effect: It can increase blood flow in the cochlear arterioles, improving circulation to the vestibular organs.
Antiepileptic effect: This product can block the pathological calcium overload in nerve cells, preventing episodic depolarization and cellular discharge, thereby inhibiting epileptic seizures.
Protecting myocardium: significantly reduces ischemic heart damage;
Effect on improving kidney function: Can be used for chronic renal failure;
Additionally, this product also has antihistamine effects.